DOVP Insider Trading Activity and SEC Form 4 Filings
DOVP insider trading summary
No open-market insider purchases or sales of Dov Pharmaceutical Inc (DOVP) have been reported on SEC Form 4 in the past 12 months.
Latest DOVP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 19, 2008 | Joseph S Zakrzewski | Director | Buy | $2K (772,327 @ $0.00) |
| Sep 30, 2008 | Joseph S Zakrzewski | Director | Buy | $5K (125,000 @ $0.04) |
| Sep 15, 2008 | Joseph S Zakrzewski | Director | Buy | $611 (16,500 @ $0.04) |
| Sep 12, 2008 | Joseph S Zakrzewski | Director | Buy | $370 (10,000 @ $0.04) |
| Sep 9, 2008 | Joseph S Zakrzewski | Director | Buy | $49 (1,330 @ $0.04) |
| Sep 8, 2008 | Joseph S Zakrzewski | Director | Buy | $2K (51,500 @ $0.04) |
| Sep 5, 2008 | Joseph S Zakrzewski | Director | Buy | $261 (7,051 @ $0.04) |
| Aug 27, 2008 | Joseph S Zakrzewski | Director | Buy | $7K (200,000 @ $0.04) |
| Jul 16, 2008 | Joseph S Zakrzewski | Director | Buy | $378 (10,495 @ $0.04) |
| Jun 30, 2008 | Joseph S Zakrzewski | Director | Buy | $3K (75,826 @ $0.04) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.